Xeomin vs. Botox: What Is the Difference and Which Is Right for You?

If you are researching xeomin vs botox, you have probably noticed that almost every article repeats the same line: "they are both botulinum toxin type A." That is true, and it is also where most explanations stop. So if the active ingredient is the same, what is actually different between these two injectables, and why does that difference matter when you are sitting in the consultation chair? At Heritage Wellness & Med Spa in Crescent Springs, KY, this question comes up almost every day, and the honest answer is that the two products behave more alike than they do differently. The small distinctions, though, can make one a better fit than the other depending on your goals, your history with neurotoxins, and your budget.

This guide breaks down the science of xeomin vs botox in plain language, compares onset, duration and cost, and walks through how Hallie, RN and the team at Heritage approach the choice during your consultation. By the end, you should know which product is likely to be a better starting point for you, and what questions to bring to your first appointment.

What Are Botox and Xeomin?

Botox (onabotulinumtoxinA) is the original brand-name botulinum toxin type A, manufactured by AbbVie's Allergan division. It received FDA approval for cosmetic use in the glabellar lines (the "11s" between the eyebrows) in 2002, although it had been used medically for blepharospasm and strabismus since the late 1980s. Today, Botox is approved for crow's feet, forehead lines, and a range of medical indications including chronic migraine, hyperhidrosis, cervical dystonia, and overactive bladder. It is by far the most recognized name in the category and typically dominates conversation around fine lines and wrinkles.

Xeomin (incobotulinumtoxinA) is manufactured by Merz Aesthetics and received FDA approval for cosmetic use in the glabellar lines in 2011, nearly a decade after Botox. Merz markets Xeomin as a "naked" or "pure" neurotoxin, which is the marketing shorthand for a real chemistry difference: the Xeomin formulation has had its accessory or complexing proteins removed during manufacturing, leaving only the active 150 kDa botulinum toxin molecule. Both products are FDA approved, both are produced under tight pharmaceutical-grade quality controls, and both have well-established safety profiles when administered by a trained, licensed injector.

How Do Botox and Xeomin Work?

To understand the xeomin vs botox conversation, it helps to know what these neurotoxins actually do at the cellular level. Both products work by temporarily blocking the release of acetylcholine, the neurotransmitter that signals muscles to contract. When a tiny dose is injected into a specific facial muscle, that muscle stops receiving the "contract" signal for a period of weeks to months. Without repeated contraction, the overlying skin gets a chance to smooth out, which is why dynamic lines (the wrinkles that appear when you frown, raise your eyebrows or squint) soften after treatment.

Here is where the "naked molecule" point matters. The botulinum toxin molecule itself is the active 150 kDa neurotoxin. In nature and in standard formulations, this active molecule travels surrounded by larger "complexing" or accessory proteins that act like packaging. Botox is formulated with these complexing proteins still attached. Xeomin is formulated without them. Once the product is injected and the molecule reaches its target nerve terminal, the effect is the same: acetylcholine release is blocked and the muscle relaxes.

Why does the protein difference matter? Some studies suggest that the additional accessory proteins in standard formulations may, over time and over many treatment cycles, contribute to the immune system producing antibodies against the toxin in a small subset of patients. When that happens, treatments may become progressively less effective, a phenomenon sometimes called "botulinum toxin resistance." Because Xeomin lacks these complexing proteins, it carries a theoretically lower risk of immunogenicity. The clinical evidence is still evolving, and true antibody-mediated resistance is uncommon, but for long-time Botox patients who feel their treatments are not lasting as long as they used to, switching to Xeomin is a conversation worth having.

Comparing Onset, Duration and Longevity

For most patients, the day-to-day experience of xeomin vs botox is remarkably similar. Onset of visible effect typically begins around days 3 to 5 after injection, with peak smoothing usually visible at the 2-week mark. Some studies suggest Xeomin may have a marginally faster onset in some patients, possibly because the smaller, naked molecule diffuses through tissue more readily, but the difference is usually subtle and not consistently reported across all clinical trials.

Duration is similar for both products. Studies generally report that the muscle-relaxing effect typically lasts 3 to 4 months in most patients, after which the treated muscle gradually regains function and the lines re-emerge. Individual factors matter much more than the brand chosen: how active the treated muscle is, how strong your metabolism is, whether you are athletic or do strenuous exercise frequently, and the dose used all influence how long results actually last. Some patients report Xeomin lasting slightly longer or shorter than Botox in their personal experience, but in head-to-head studies the duration is comparable. If you are searching for which lasts longer, xeomin vs botox, the honest answer is: for most people, they last about the same.

FDA-Approved and Off-Label Uses

Botox holds a wider range of FDA-approved indications than Xeomin, which is partly a function of how long it has been on the market. Cosmetic FDA-approved areas for Botox include glabellar lines, lateral canthal lines (crow's feet) and forehead lines. Medically, Botox is approved for chronic migraine, severe underarm hyperhidrosis, overactive bladder, urinary incontinence, cervical dystonia, blepharospasm, strabismus, and several other conditions.

Xeomin is currently FDA approved for glabellar lines cosmetically, and medically for cervical dystonia, blepharospasm, upper limb spasticity, and chronic sialorrhea. In aesthetic practice, however, both products are routinely used "off-label" by experienced injectors for areas like crow's feet, forehead lines, masseter muscle reduction (for jaw slimming and TMJ relief), lip flip, brow lift, gummy smile, neck bands and underarm hyperhidrosis. Off-label use is legal, common, and well within the standard of care when performed by qualified medical professionals such as the registered nurse injectors at Heritage. The American Society for Dermatologic Surgery has published consensus guidelines on botulinum toxin use that cover both on-label and off-label aesthetic applications.

Who Is the Ideal Candidate for Each?

For most first-time neurotoxin patients, either Botox or Xeomin is a reasonable starting point. The decision usually comes down to personal preference, current promotions, manufacturer loyalty programs (Allergan's Allē versus Merz's Xperience), and what your provider recommends based on your anatomy and goals.

Patients who tend to do best with Botox include first-timers who want the most studied, most familiar option, patients on Allē rewards who want to accumulate points, and those whose past results with Botox have been excellent and consistent. Patients who tend to do best with Xeomin include long-time Botox users who feel their results are getting shorter or weaker (a possible sign of subclinical immunogenicity), patients with known sensitivities or who simply prefer a formulation without complexing proteins, and those enrolled in or interested in the Merz Xperience rewards program.

A specific population worth highlighting is patients who suspect they have developed Botox resistance. If you have been getting Botox consistently for several years and notice that the same dose is wearing off in 8 to 10 weeks instead of 12 to 16, switching to Xeomin is a reasonable strategy. Some studies suggest that the absence of complexing proteins in Xeomin may help "reset" the response in certain patients, although this is an area of ongoing research and not every patient will experience the difference.

Cost Comparison: Is Xeomin Cheaper Than Botox?

Pricing for botulinum toxin is almost always quoted per unit rather than per syringe or per area, because the dose required varies by anatomy, muscle strength and goal. At most U.S. medical spas, Botox typically prices in the $12 to $18 per unit range, and Xeomin typically prices slightly lower, in the $10 to $14 per unit range. The wholesale cost difference between the two products is real but small, and many med spas pass that small saving on to the patient.

Importantly, unit-for-unit, Botox and Xeomin are dosed approximately 1:1. If you typically receive 20 units of Botox in your glabella, you will typically receive about 20 units of Xeomin in the same area. So when patients ask, "how many units of xeomin vs botox do I need?", the practical answer is: a similar number. That means a slightly lower per-unit Xeomin price can translate to real savings over a year of treatments, particularly for patients treating multiple areas. At Heritage Wellness & Med Spa, current per-unit pricing for both products, along with any active loyalty rewards or quarterly events, is reviewed transparently during your complimentary consultation so you can make an informed choice without pressure.

What to Expect at Your Heritage Consultation

The right way to choose between xeomin vs botox is not to read one more article. It is to sit down with a qualified injector who can assess your facial anatomy, your goals, your history and your budget, and recommend the right product and the right dose for you. At Heritage Wellness & Med Spa in Crescent Springs, KY, your consultation begins with Hallie, RN, our Botox and filler-certified primary aesthetic provider, taking a full intake. She will look at your dynamic and static lines, ask about any prior neurotoxin treatments and how those went, and walk through realistic expectations for both products.

If you are new to neurotoxins, Hallie will typically suggest a conservative starting dose so you can see how your face responds before scaling up. If you are an experienced patient considering switching from Botox to Xeomin, she will help you map current dosing across to the equivalent Xeomin dose. You can learn more about Xeomin injections at Heritage Wellness & Med Spa and Botox injections in Crescent Springs on our dedicated treatment pages, or browse the full range of injectable treatments at Heritage Wellness & Med Spa to see how neurotoxins fit alongside dermal fillers and other aesthetic options. We promise a no-pressure, relationship-driven experience: if neither product is the best next step for your goals, we will tell you that, too.

Frequently Asked Questions

Is Xeomin the same as Botox?

No, but they are close cousins. Xeomin and Botox are both botulinum toxin type A neurotoxins that work by temporarily relaxing the targeted muscle. The active molecule is essentially the same in both products. The difference is that Xeomin is formulated as a "naked" molecule without the accessory complexing proteins that Botox includes. In practical terms, both products soften dynamic wrinkles, both typically last 3 to 4 months, and both are FDA approved for cosmetic use in the glabellar lines.

Does Xeomin work as well as Botox?

For most patients, yes. Head-to-head clinical studies have generally shown comparable efficacy between Xeomin and Botox at equivalent doses. Onset typically occurs at 3 to 5 days, peak effect at around 2 weeks, and duration around 3 to 4 months for both. Individual response varies, and some patients prefer one product over the other based on subtle personal differences in onset speed or feel, but neither is clinically "stronger" than the other in routine cosmetic use.

Can you switch from Botox to Xeomin?

Yes. Switching from Botox to Xeomin is straightforward and common, particularly for patients who feel their Botox results are not lasting as long as they used to or who want to try a formulation without complexing proteins. Dosing is approximately 1:1 between the two products, so an experienced injector can map your current Botox dose directly across to Xeomin. There is no need to "wash out" your previous Botox; you simply schedule your next appointment with the new product.

How many units of Xeomin vs Botox do I need?

The unit count is typically very similar between the two products because they are dosed approximately 1:1. Common starting ranges include 20 to 25 units for the glabella (the "11s"), 8 to 16 units for crow's feet (4 to 8 per side), and 10 to 20 units for forehead lines, although these are general ranges and your actual dose depends on your muscle strength, anatomy and goals. During your consultation, your provider will recommend a specific dose for each area based on a physical assessment.

Is Xeomin cheaper than Botox?

Often, yes, by a small margin. Xeomin's per-unit price is typically a few dollars below Botox at many U.S. medical spas, although exact pricing varies by location, provider experience and current promotions. Because dosing is approximately 1:1, those per-unit savings translate into modest real savings per treatment. That said, cost should not be the only factor. The right product for you depends on your history, your goals and your provider's recommendation. Heritage Wellness & Med Spa in Crescent Springs, KY publishes transparent per-unit pricing during your consultation, along with any active loyalty rewards from Allergan or Merz Aesthetics, so you can make a confident decision.

Ready to talk through xeomin vs botox in person? Book a complimentary consultation with Hallie, RN at Heritage Wellness & Med Spa in Crescent Springs, KY by calling (859) 900-4090 or visiting our contact page.